What is the Current Share Price of Onyx Biotec Ltd?
- Answer Field
-
Onyx Biotec Ltd share price is for NSE ₹ 29.80 & for BSE ₹ 0.00 as on May 25 2026 02:44 PM.
As of the latest trading session, ONYX BIOTEC LIMITED is trading at ₹29.8, up by ₹0.00 or 0.00% from its previous close. The stock has moved between ₹29.80 and ₹29.80 today. Over the past year, the stock has delivered a return of -42.58%. In the last month, it has returned -7.59%.
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 32.16 | 13.67 | 1.55 | 246.45 | 23.12 | 40.00 |
| BLISS GVS PHARMA LTD | 317.60 | 24.29 | 2.81 | 3359.86 | 118.35 | 329.45 |
| CIPLA LTD | 1413.50 | 27.70 | 3.31 | 114182.61 | 1165.55 | 1672.20 |
| FERMENTA BIOTECH LTD. | 302.00 | 10.07 | 2.27 | 888.82 | 256.40 | 399.00 |
| GLAXOSMITHKLINE PHARMACEUTICAL | 2300.10 | 38.33 | 17.18 | 38965.08 | 2218.00 | 3515.95 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 32.16 | 22.49 | 4.14 | 246.45 | 23.12 | 40.00 |
| AMRUTANJAN HEALTH CARE LTD. | 560.60 | 25.13 | 4.37 | 1620.73 | 490.00 | 789.95 |
| ASTRAZENECA PHARMA INDIA LTD. | 8795.40 | 105.70 | 27.52 | 21988.50 | 7630.00 | 10653.05 |
| BLISS GVS PHARMA LTD | 317.60 | 34.15 | 2.90 | 3359.86 | 118.35 | 329.45 |
Choose a Plan That Suits Your Goals and Needs
Freedom Pack
Subscription Charge : FREE
Professional Pack
Subscription Fee : ₹2,500 Yearly
Signature
Account Opening : FREE
*Note: The Freedom Pack is free for the first year and has an annual fee of ₹431 from the second year onwards.
Onyx Biotec Limited was incorporated as Onyx Biotec Private Limited', pursuant to a Certificate of Incorporation dated May 13, 2005 issued by the Registrar of Companies, Punjab, H.P. & Chandigarh. Further, Company converted into a Public Limited and the name was changed to Onyx Biotec Limited' and a fresh Certificate of Incorporation dated July 23, 2024 was issued by the Registrar of Companies, Central Processing Centre.
Onyx started its operation in pharmaceutical industry with sterile water for injections with capacity of 2 lacs units per day in year 2010. Since then, Onyx is engaged in Manufacturing of Pharmaceutical Products such as sterile water ampoule, dry injection, dry syrup etc. to major corporations, which includes the top pharma companies.
Presently, the Company manufactures Sterile Water for Injections, and acts as a pharmaceutical contract manufacturer offering a comprehensive range of Dry Powder Injections and Dry Syrup for India and overseas. The core business is on providing end-to-end product development and manufacturing solutions to clients. The service include preparation and filing of regulatory dossiers in the Indian and global markets.
The Company has Unit I and Unit II manufacturing plants in Solan District of Himachal Pradesh. Unit-1 was started in 2010, for the production of Sterile Water for Injections (SWFI) ampoules in FFS technology. Having 6 production machines, and a list of esteemed customers like Aristo, Mankind, Dr Reddy's, Sun Pharma, Macleods etc, it has established itself as a major player in this field.
The Company later on, enhanced the capacity expansion from 130 million unit per annum to 230 million units per annum capacity in 2017-18.
Unit-2 came into manufacturing in 2023, involved in the manufacturing of Dry Powder Injections, and Dry Powder Syrup (Cephalosporin) range. It was granted WHO- GMP certificate by the CDSCO in May 2024.
48,10,000 equity shares of Rs 10/- were allotted pursuant to IPO by raising Rs 29.34 crores via offer for sale on November 19, 2024.
Onyx Biotec Ltd share price is for NSE ₹ 29.80 & for BSE ₹ 0.00 as on May 25 2026 02:44 PM.
The market cap of Onyx Biotec Ltd for NSE ₹ 54.00 & for BSE ₹ 0.00 as on May 25 2026 02:44 PM.
The 52 Week High and Low of Onyx Biotec Ltd for NSE is ₹ 56.00 and ₹ 24.20 and for BSE is ₹ 0.00 and ₹ 0.00.
The 1 year returns on the stock has been -42.58%.
As on May 25 2026 02:44 PM the price-to-earnings (PE) ratio for Onyx Biotec Ltd share is -248.33.
As on May 25 2026 02:44 PM, the price-to-book (PB) ratio for Onyx Biotec Ltd share is 30.56.
You can trade in Onyx Biotec Ltd shares with Bajaj Broking by opening a demat account.
To buy Onyx Biotec Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Onyx Biotec Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found